President Donald Trump hinted at the possibility of the United States rejoining the World Health Organization (WHO), days after initiating the country’s withdrawal. Speaking at a rally in Las Vegas, Trump stated, “Maybe we would consider doing it again... They would have to clean it up.” The U.S. is set to leave the WHO on January 22, 2026, following Trump’s decision after being sworn in for a second term.
Trump criticized the WHO’s handling of the COVID-19 pandemic and other global health crises, expressing frustration that the U.S. contributes significantly more funding than China despite its smaller population. The U.S. currently accounts for approximately 18% of the WHO’s $6.8 billion budget for 2024-2025, making it the organization’s largest financial supporter.
In his speech, Trump also discussed expanding economic ties with Saudi Arabia. He shared that Crown Prince Mohammed bin Salman recently pledged $600 billion in investments and trade over the next four years. Trump said he aims to increase this figure to $1 trillion to boost the U.S. economy.
Trump’s remarks highlight his focus on prioritizing U.S. interests in international organizations and partnerships. Whether the U.S. returns to the WHO will likely depend on reforms addressing Trump’s concerns over funding disparities and operational efficiency.
These developments come as Trump seeks to reshape global alliances while emphasizing stronger investment ties with key partners like Saudi Arabia.


Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
China Warns US Arms Sales to Taiwan Could Disrupt Trump’s Planned Visit
Norway Opens Corruption Probe Into Former PM and Nobel Committee Chair Thorbjoern Jagland Over Epstein Links
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Pentagon Ends Military Education Programs With Harvard University
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Iran–U.S. Nuclear Talks in Oman Face Major Hurdles Amid Rising Regional Tensions
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Nighttime Shelling Causes Serious Damage in Russia’s Belgorod Region Near Ukraine Border
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Trump Allows Commercial Fishing in Protected New England Waters
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Trump Says “Very Good Talks” Underway on Russia-Ukraine War as Peace Efforts Continue
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 



